- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel melanoma therapy ; volume:5 ; number:1 ; day:8 ; month:8 ; year:2016 ; pages:1-10 ; date:12.2015
Experimental hematology & oncology ; 5, Heft 1 (8.8.2016), 1-10, 12.2015
- Urheber
-
Hsueh, Eddy C.
- Beteiligte Personen und Organisationen
-
Gorantla, Kalyan C.
SpringerLink (Online service)
- DOI
-
10.1186/s40164-016-0054-1
- URN
-
urn:nbn:de:1111-201609056655
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hsueh, Eddy C.
- Gorantla, Kalyan C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapy of advanced melanoma
Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
Optimizing Regional Therapy for Melanoma
Role of arenavirus therapy in melanoma
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Multi-organ landscape of therapy-resistant melanoma
(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling
Novel combination therapies for BRAF-mutant melanoma
Novel treatment paradigms for metastatic uveal melanoma
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
Anti- cancer therapy: Blazing the trail with melanoma
Therapy of advanced melanoma
Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
Optimizing Regional Therapy for Melanoma
Role of arenavirus therapy in melanoma
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Multi-organ landscape of therapy-resistant melanoma
(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling
Novel combination therapies for BRAF-mutant melanoma
Novel treatment paradigms for metastatic uveal melanoma
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
Anti- cancer therapy: Blazing the trail with melanoma
Therapy of advanced melanoma
Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
A novel combination treatment against melanoma with NRAS mutation and therapy resistance
Optimizing Regional Therapy for Melanoma
Role of arenavirus therapy in melanoma
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Multi-organ landscape of therapy-resistant melanoma
(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling
Novel combination therapies for BRAF-mutant melanoma
Novel treatment paradigms for metastatic uveal melanoma
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy